195 related articles for article (PubMed ID: 30097462)
1. Elevated ecto-5'-nucleotidase: a missing pathogenic factor and new therapeutic target for sickle cell disease.
Liu H; Adebiyi M; Liu RR; Song A; Manalo J; Wen YE; Wen AQ; Weng T; Ko J; Idowu M; Kellems RE; Eltzschig HK; Blackburn MR; Juneja HS; Xia Y
Blood Adv; 2018 Aug; 2(15):1957-1968. PubMed ID: 30097462
[TBL] [Abstract][Full Text] [Related]
2. Beneficial Role of Erythrocyte Adenosine A2B Receptor-Mediated AMP-Activated Protein Kinase Activation in High-Altitude Hypoxia.
Liu H; Zhang Y; Wu H; D'Alessandro A; Yegutkin GG; Song A; Sun K; Li J; Cheng NY; Huang A; Edward Wen Y; Weng TT; Luo F; Nemkov T; Sun H; Kellems RE; Karmouty-Quintana H; Hansen KC; Zhao B; Subudhi AW; Jameson-Van Houten S; Julian CG; Lovering AT; Eltzschig HK; Blackburn MR; Roach RC; Xia Y
Circulation; 2016 Aug; 134(5):405-21. PubMed ID: 27482003
[TBL] [Abstract][Full Text] [Related]
3. Elevated ecto-5'-nucleotidase-mediated increased renal adenosine signaling via A2B adenosine receptor contributes to chronic hypertension.
Zhang W; Zhang Y; Wang W; Dai Y; Ning C; Luo R; Sun K; Glover L; Grenz A; Sun H; Tao L; Zhang W; Colgan SP; Blackburn MR; Eltzschig HK; Kellems RE; Xia Y
Circ Res; 2013 May; 112(11):1466-78. PubMed ID: 23584256
[TBL] [Abstract][Full Text] [Related]
4. Adenosine signaling in normal and sickle erythrocytes and beyond.
Zhang Y; Xia Y
Microbes Infect; 2012 Aug; 14(10):863-73. PubMed ID: 22634345
[TBL] [Abstract][Full Text] [Related]
5. Elevated adenosine signaling via adenosine A2B receptor induces normal and sickle erythrocyte sphingosine kinase 1 activity.
Sun K; Zhang Y; Bogdanov MV; Wu H; Song A; Li J; Dowhan W; Idowu M; Juneja HS; Molina JG; Blackburn MR; Kellems RE; Xia Y
Blood; 2015 Mar; 125(10):1643-52. PubMed ID: 25587035
[TBL] [Abstract][Full Text] [Related]
6. Ecto-5'-nucleotidase, CD73, is an endothelium-derived hyperpolarizing factor synthase.
Ohta M; Toyama K; Gutterman DD; Campbell WB; Lemaître V; Teraoka R; Miura H
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):629-36. PubMed ID: 23288168
[TBL] [Abstract][Full Text] [Related]
7. Opiorphin-dependent upregulation of CD73 (a key enzyme in the adenosine signaling pathway) in corporal smooth muscle cells exposed to hypoxic conditions and in corporal tissue in pre-priapic sickle cell mice.
Fu S; Davies KP
Int J Impot Res; 2015 Jul; 27(4):140-5. PubMed ID: 25833166
[TBL] [Abstract][Full Text] [Related]
8. Discovery of Potent and Selective Methylenephosphonic Acid CD73 Inhibitors.
Sharif EU; Kalisiak J; Lawson KV; Miles DH; Newcomb E; Lindsey EA; Rosen BR; Debien LPP; Chen A; Zhao X; Young SW; Walker NP; Sträter N; Scaletti ER; Jin L; Xu G; Leleti MR; Powers JP
J Med Chem; 2021 Jan; 64(1):845-860. PubMed ID: 33399453
[TBL] [Abstract][Full Text] [Related]
9. Ecto-5'-nucleotidase CD73 modulates the innate immune response to influenza infection but is not required for development of influenza-induced acute lung injury.
Aeffner F; Woods PS; Davis IC
Am J Physiol Lung Cell Mol Physiol; 2015 Dec; 309(11):L1313-22. PubMed ID: 26432867
[TBL] [Abstract][Full Text] [Related]
10. Erythrocyte adaptive metabolic reprogramming under physiological and pathological hypoxia.
D'Alessandro A; Xia Y
Curr Opin Hematol; 2020 May; 27(3):155-162. PubMed ID: 32141895
[TBL] [Abstract][Full Text] [Related]
11. Erythrocyte Adenosine A2B Receptor-Mediated AMPK Activation: A Missing Component Counteracting CKD by Promoting Oxygen Delivery.
Peng Z; Luo R; Xie T; Zhang W; Liu H; Wang W; Tao L; Kellems RE; Xia Y
J Am Soc Nephrol; 2019 Aug; 30(8):1413-1424. PubMed ID: 31278195
[TBL] [Abstract][Full Text] [Related]
12. Detrimental effects of adenosine signaling in sickle cell disease.
Zhang Y; Dai Y; Wen J; Zhang W; Grenz A; Sun H; Tao L; Lu G; Alexander DC; Milburn MV; Carter-Dawson L; Lewis DE; Zhang W; Eltzschig HK; Kellems RE; Blackburn MR; Juneja HS; Xia Y
Nat Med; 2011 Jan; 17(1):79-86. PubMed ID: 21170046
[TBL] [Abstract][Full Text] [Related]
13. CD73-dependent generation of adenosine and endothelial Adora2b signaling attenuate diabetic nephropathy.
Tak E; Ridyard D; Kim JH; Zimmerman M; Werner T; Wang XX; Shabeka U; Seo SW; Christians U; Klawitter J; Moldovan R; Garcia G; Levi M; Haase V; Ravid K; Eltzschig HK; Grenz A
J Am Soc Nephrol; 2014 Mar; 25(3):547-63. PubMed ID: 24262796
[TBL] [Abstract][Full Text] [Related]
14. CD73-TNAP crosstalk regulates the hypertrophic response and cardiomyocyte calcification due to α1 adrenoceptor activation.
Gan XT; Taniai S; Zhao G; Huang CX; Velenosi TJ; Xue J; Urquhart BL; Karmazyn M
Mol Cell Biochem; 2014 Sep; 394(1-2):237-46. PubMed ID: 24894822
[TBL] [Abstract][Full Text] [Related]
15. Involvement of CD73 and A2B Receptor in Radiation-Induced DNA Damage Response and Cell Migration in Human Glioblastoma A172 Cells.
Kitabatake K; Kaji T; Tsukimoto M
Biol Pharm Bull; 2021 Feb; 44(2):197-210. PubMed ID: 33268695
[TBL] [Abstract][Full Text] [Related]
16. Targeting CD73 and downstream adenosine receptor signaling in triple-negative breast cancer.
Allard B; Turcotte M; Stagg J
Expert Opin Ther Targets; 2014 Aug; 18(8):863-81. PubMed ID: 24798880
[TBL] [Abstract][Full Text] [Related]
17. Specific blockade CD73 alters the "exhausted" phenotype of T cells in head and neck squamous cell carcinoma.
Deng WW; Li YC; Ma SR; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Int J Cancer; 2018 Sep; 143(6):1494-1504. PubMed ID: 29663369
[TBL] [Abstract][Full Text] [Related]
18. Altered E-NTPDase/E-ADA activities and CD39 expression in platelets of sickle cell anemia patients.
Castilhos LG; Doleski PH; Adefegha SA; Becker LV; Ruchel JB; Leal DB
Biomed Pharmacother; 2016 Apr; 79():241-6. PubMed ID: 27044834
[TBL] [Abstract][Full Text] [Related]
19. Elevated placental adenosine signaling contributes to the pathogenesis of preeclampsia.
Iriyama T; Sun K; Parchim NF; Li J; Zhao C; Song A; Hart LA; Blackwell SC; Sibai BM; Chan LN; Chan TS; Hicks MJ; Blackburn MR; Kellems RE; Xia Y
Circulation; 2015 Feb; 131(8):730-41. PubMed ID: 25538227
[TBL] [Abstract][Full Text] [Related]
20. Identification of allosteric inhibitors of the ecto-5'-nucleotidase (CD73) targeting the dimer interface.
Rahimova R; Fontanel S; Lionne C; Jordheim LP; Peyrottes S; Chaloin L
PLoS Comput Biol; 2018 Jan; 14(1):e1005943. PubMed ID: 29377887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
